Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma.

about

Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma.

Item

http://www.wikidata.org/entity/Q54979771

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Application of molecular targe ...... neck squamous cell carcinoma.

@en

Application of molecular targe ...... neck squamous cell carcinoma.

@nl

type

Item

label

Application of molecular targe ...... neck squamous cell carcinoma.

@en

Application of molecular targe ...... neck squamous cell carcinoma.

@nl

prefLabel

Application of molecular targe ...... neck squamous cell carcinoma.

@en

Application of molecular targe ...... neck squamous cell carcinoma.

@nl

P1476

Application of molecular targe ...... neck squamous cell carcinoma.

@en

P2093

Ludmiła Grzybowska-Szatkowska

http://www.w3.org/2001/XMLSchema#string

Paulina Kozakiewicz

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Epidemiologic trends in head and neck cancer and aids in diagnosis

Current role of EGF receptor monoclonal antibodies and tyrosine kinase inhibitors in the management of head and neck squamous cell carcinoma

Human papillomavirus and survival of patients with oropharyngeal cancer.

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.

Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations.

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Screening of kinase inhibitors targeting BRAF for regulating autophagy based on kinase pathways

Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1

Targeting the phosphoinositide 3-kinase pathway in cancer

P304

7497-7505

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.8300

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29725456

http://www.w3.org/2001/XMLSchema#string

P921

head and neck squamous cell carcinoma

P932

5920345

http://www.w3.org/2001/XMLSchema#string